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Abstract
Rationale: The etiology of sarcoidosis is unknown, but microbial
agents are suspected as triggers.
Objectives:We sought to identify bacterial, fungal, or viral lineages
in specimens from patients with sarcoidosis enriched relative to
control subjects usingmetagenomicDNA sequencing. Because DNA
from environmental contamination contributes disproportionately
to samples with low authentic microbial content, we developed
improved methods for ﬁltering environmental contamination.
Methods:We analyzed specimens from subjects with sarcoidosis
(n = 93), control subjects without sarcoidosis (n = 72), and various
environmental controls (n = 150). Sarcoidosis specimens consisted of
two independent sets of formalin-ﬁxed, parafﬁn-embedded lymph
node biopsies, BAL, Kveim reagent, and fresh granulomatous spleen
from a patient with sarcoidosis. All specimens were analyzed by
bacterial 16S and fungal internal transcribed spacer ribosomal RNA
gene sequencing. In addition, BAL was analyzed by shotgun
sequencing of fractions enriched for viral particles, and Kveim and
spleen were subjected to whole-genome shotgun sequencing.
Measurements and Main Results: In one tissue set, fungi in the
Cladosporiaceae family were enriched in sarcoidosis compared with
nonsarcoidosis tissues; in the other tissue set, we detected enrichment
of several bacterial lineages in sarcoidosis but not Cladosporiaceae.
BAL showed limited enrichment of Aspergillus fungi. Several
microbial lineages were detected in Kveim and spleen, including
Cladosporium. No microbial lineage was enriched in more than one
sample type after correction for multiple comparisons.
Conclusions:Metagenomic sequencing revealed enrichment of
microbes in single types of sarcoidosis samples but limited
concordance across sample types. Statistical analysis accounting
for environmental contamination was essential to avoiding false
positives.
Keywords: sarcoidosis; metagenomic; microbiome; bacterial 16S
ribosomal RNA; fungal internal transcribed spacer ribosomal RNA
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Sarcoidosis is a multisystem disease
characterized by an aberrant immune
response that results in inﬂammation and
granuloma formation. Sarcoidosis is
believed to have an antigenic or
inﬂammatory trigger that initiates the
immune reaction in a susceptible host (1–3).
Several susceptibility genes have been
identiﬁed (4, 5), but the trigger remains
obscure. Granulomatous inﬂammation is
commonly seen in responses to microbial
agents, as are other features of sarcoidosis
immunopathology, such as oligoclonal CD4
T-cell expansion and T-helper cell type 1
polarization (1). No microbial cause has
been deﬁnitively established for sarcoidosis,
but candidates include species of
Mycobacterium (6–9), as well as fungi (10)
and Propionibacterium acnes (11, 12), a
common skin bacteria.
The ability to detect rare or
unculturable microbes has improved
dramatically using deep DNA sequencing
(13–15). Several studies have applied
bacterial 16S ribosomal RNA (rRNA) gene
sequencing to sarcoidosis, with differing
results (6, 16, 17). No prior studies have
interrogated fungal lineages with tag
sequencing or used shotgun metagenomic
sequencing for comprehensive studies of
total DNA or puriﬁed viral particles.
We performed an intensive
metagenomic investigation of multiple
sarcoidosis sample sets using 16S rRNA gene
sequencing to capture bacteria, internal
transcribed spacer (ITS) sequencing for fungi,
and whole-genome shotgun sequencing
to characterize all microbes. Samples
(Table 1) include two independent sets of
formalin-ﬁxed, parafﬁn-embedded (FFPE)
granulomatous tissue biopsies from patients
with newly identiﬁed sarcoidosis and control
patients (sets A and B), and BAL from
patients with newly diagnosed untreated stage
II/III sarcoidosis and healthy control subjects
(set C). We also interrogated a sample of the
Kveim reagent (set D) (which is made from
sarcoidosis-affected spleen and was used
historically for sarcoidosis diagnosis by
intradermal injection and monitoring for
granuloma formation [18–20]), along with
fresh granulomatous spleen from a patient
with sarcoidosis (set E).
An often-underappreciated feature of
sequence-based microbial detection is that
at low levels of true signal, sequences can be
dominated by microbial DNA from
environmental sources introduced during
sample collection, storage, DNA extraction,
or other steps (21, 22). This particularly
confounds analysis of samples in which the
authentic content of microbial DNA is low,
such as lung bronchoscopies and tissue
biopsies (21, 23–25). Even with the most
careful preparation, however, there is often
no way to eliminate environmental
sequences completely, so further
computational and statistical methods must
be used to identify contamination. We thus
used extensive environmental sampling
and applied novel statistical modeling to
minimize false-positive calls. By
investigating several independent sample
sets and tissue types, we were able to
interrogate whether sarcoidosis-enriched
sequences appeared consistently across
sample sets. Some of the results of these
studies have been previously reported in
the form of an abstract (26).
Methods
Archived Tissue Samples
Two sets of FFPE sarcoidosis and control
tissues were analyzed. Set A (from Gdan´sk)
were mediastinal lymph nodes showing
noncaseating granulomas typical of
sarcoidosis and negative by staining for
acid-fast or fungal elements. Controls were
mediastinal lymph nodes with normal or
nonspeciﬁc reactive histology. Set B (from
Philadelphia) consisted of mediastinal
nodes containing granulomas typical of
sarcoidosis and negative by fungal and
acid-fast stain. Controls were histologically
normal nodes from cancer staging
procedures. Stored specimens were
retrieved and 10-mm cuts taken under
aseptic conditions. Parafﬁn block
environmental controls were cut
concurrently with tissue specimens. For set
A, these were matched from the same block
as tissue; for set B, they were not from
the same block.
BAL
BAL ﬂuid (set C) was obtained from subjects
undergoing diagnostic bronchoscopy (from
Philadelphia) for suspected new diagnosis
of pulmonary sarcoidosis who had chest
X-rays consistent with parenchymal
(Scadding stage II/III) involvement. Subjects
included here had sarcoidosis conﬁrmed
by standard criteria and exclusion of
alternative diagnoses. BAL was performed
using standard clinical protocols.
Control BAL was obtained from healthy
volunteers who underwent research
bronchoscopy (23). Before bronchoscopy,
an environmental control (bronchoscope
prewash) was obtained as previously
described (23). BAL and prewash were
At a Glance Summary
Scientiﬁc Knowledge on the
Subject: Sarcoidosis is believed to be
an aberrant immune response to an
unknown antigenic trigger in a
genetically susceptible host. Microbial
agents are suspected as triggers,
although evidence is inconclusive.
Metagenomic deep sequencing can
quantitatively detect microbes that are
unsuspected and/or unculturable, but it
has not been systematically applied to
sarcoidosis.
What This Study Adds to the
Field: Targeted identiﬁcation of all
bacteria and fungi using 16S and
internal transcribed spacer sequence
tags, shotgun sequencing of all nucleic
acids in viral preparations, and whole-
genome sequencing was applied to
sarcoidosis and control sample sets of
lymphoid tissue, BAL, sarcoidosis
spleen, and the Kveim reagent. Because
environmentally derived sequences can
confound detection in specimens with
low authentic microbial content,
extensive environmental sequence
controls were incorporated. This
analysis revealed enrichment of speciﬁc
taxa in sarcoidosis compared with
nonsarcoidosis specimens within
individual sample sets, such as the
fungus Cladosporium, although no
taxa were consistently sarcoidosis
enriched across sample sets. This
study identiﬁes agents as potential
candidates for further validation.
Analysis without accounting for
environmentally derived sequences
would have yielded multiple spurious
hits, demonstrating the need for
rigorous attention to environmental
microbial sequences in metagenomic
study of lung diseases. We provide a
robust model to account for
environmental contamination that is
broadly applicable to other
metagenomic studies.
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placed immediately on ice and stored at
2808C until analysis.
Kveim and Spleen Tissue
An aliquot of Kveim reagent ([19]; set D)
was analyzed that was prepared at Mt. Sinai
Hospital (New York) for clinical diagnostic
use as described (27) and stored under
sterile conditions.
Sarcoidosis-involved spleen (set E) was
obtained from an individual with long-
standing disease (from Philadelphia),
previously but not currently treated, who
underwent splenectomy for symptomatic
splenomegaly. Tissue was freshly dissected
from the organ and frozen at 2808C. An
aliquot of the saline used for tissue
homogenization served as a matched
environmental control.
Human Subjects
Tissue samples were obtained from
anonymized tissue archives. Bronchoscopy
and spleen donor subjects provided written
informed consent under institutional review
board–approved protocols.
Sequence Analysis of 16S and ITS
rRNA Gene Segments
Details of extraction, ampliﬁcation, Illumina
sequencing, and taxonomic assignment
are in the online supplement. The bacterial
16S ribosomal RNA gene was ampliﬁed
using V1V2 primers (see Table E2 in the
online supplement); this relatively short
amplicon was chosen to maximize
ampliﬁcation efﬁciency for rare sequences
from low–microbial biomass samples (23,
28). The fungal ribosomal RNA internal
transcribed spacer ITS1 region was
ampliﬁed using ITS1F/ITS2 primers (25,
28, 29) (Table E2). Sequences were
organized into operational taxonomic
units (OTUs) at 97% identity. Statistical
analysis was performed at the
individual OTU level and at genus and
family levels.
Virome Analysis
Virome analysis was performed on BAL
and matched prewash specimens (30, 31).
To enrich for viruses, ﬂuid was pelleted
and acellular material subject to size-
exclusion concentration, followed by
nuclease treatment to digest
nonencapsulated nucleic acids. Nucleic
acids were then extracted, and DNA was
subjected to whole-genome ampliﬁcation
using GenomiPhi. RNA was reverse
transcribed to cDNA and polymerase
chain reaction ampliﬁed. Resulting
libraries were shotgun sequenced; reads
were quality ﬁltered and then annotated
using a custom database we constructed
that included all complete bacterial,
fungal, archaeal, and viral genomes in
RefSeq release 79 (32). All nonviral
reads were removed from consideration.
We found many reads annotated to
viruses later determined to be either from
reagents or misannotation of human
reads (31), which were therefore
excluded. Details are in the online
supplement.
Whole-Genome Sequencing
DNA from sarcoidosis spleen tissue and
Kveim reagent was subjected to whole-
genome sequencing (WGS) on an Illumina
HiSeq. Reads were quality ﬁltered,
processed, and classiﬁed using Kraken (33)
with our custom database (described above),
with low-complexity regions masked
before querying. Details are in the online
supplement. The analytic pipeline is available
at https://github.com/eclarke/sunbeam.
Accessing Sequence Data
Sequence data are available in the National
Center for Biotechnology Information
Sequence Read Archive under BioProject ID
PRJNA392272.
Statistical Analysis
Code and a complete description are in the
online supplement. For sample sets A and C,
which had paired environmental controls,
we used the R package lme4 (34) to
build a generalized linear mixed effects
model (GLMM) to regress the number
of reads of a taxon against the study
group (sarcoid/healthy) and sample type
Table 1. Sample Sets Studied
Sample
Set Sample Type Study Group
No. of
Subjects
Collection
Site Bacteria Fungi
RNA
Virus
DNA
Virus
A Tissue Sarcoid 45 Gdansk 643 1,180 N/A N/A
Tissue Control 37 Gdansk 207 236 N/A N/A
Parafﬁn only (paired) Environmental control 82 Gdansk 465 1,081 N/A N/A
Blanks Reagent control 27 Gdansk 74 84 N/A N/A
B Tissue Sarcoid 30 Philadelphia 5,548 2,136 N/A N/A
Tissue Control 19 Philadelphia 2,813 2,703 N/A N/A
Blanks Reagent control 5 Philadelphia 285 55 N/A N/A
C BAL Sarcoid 16 Philadelphia 3,105 25 1 85
BAL Healthy subjects 12 Philadelphia 1,604 13 1 40
Prewash (paired) Environmental control 24 Philadelphia 823 28 4 99
Blanks Reagent control 4 Philadelphia 157 22 0 38
D Kveim reagent Sarcoid 1 New York 1,725 20 N/A 4
Water Environmental control 1 Philadelphia 1,035 3 N/A 26
E Spleen Sarcoid 1 Philadelphia 1,156 19 N/A 3
Saline wash of
instruments
Environmental control 2 Philadelphia 408 2 N/A 31
Water Reagent control 1 Philadelphia 1,035 3 N/A 26
Definition of abbreviation: N/A = not available.
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Figure 1. Dominant bacterial and fungal orders in lymph node tissue samples and matched controls (set A). The major bacterial (A) and fungal (B)
orders identified by 16S and internal transcribed spacer ribosomal RNA gene sequencing, respectively, are shown as proportions of total reads. Less-
common lineages are aggregated under “Other.” For each pair, the solid circle indicates the formalin-fixed, paraffin-embedded lymph node sample, and the
open circle indicates a slice of blank paraffin cut from the same block to serve as an environmental control. Empty (white) bar charts indicate that the sample
was either not available or had no detectable lineages. The difference in Cladosporiaceae reads between a sample and its environmental control are
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(tissue/environmental control) (Figure E1).
Environmental levels of the taxa in each
sample/control pair were captured as a
random effect. Enrichment was determined
by the signiﬁcance and directionality of
the coefﬁcient for the study group/sample
type interaction term after ﬁtting the
model. For sample set B, which did not
have matched environmental controls, we
used the R package DESeq2 (35) to
determine enrichment.
Because one could not predict a priori
whether a putative sarcoidosis-associated
microbial trigger would be a speciﬁc family,
genus, species, or even OTU, lineages were
tested at the individual OTU level and
then aggregated and tested at the species,
genus, and family levels. False discovery
rate (FDR) correction was applied at each
taxonomic level, and an FDR P value
cutoff of 0.1 was considered signiﬁcant.
Although interrogating the data at each
taxonomic level increased the risk of type I
(false positive) errors, we considered this
justiﬁed due to uncertainty over which
taxonomic level might be linked to
sarcoidosis and the exploratory nature of
the study and mitigated by the multiple
independent sample sets. Conversely,
because requiring a lineage to reach
FDR-corrected signiﬁcance in multiple
independent sample sets would increase the
likelihood of type II errors, we also
considered lineages that were signiﬁcant
after FDR correction in one sample set but
only signiﬁcant before FDR correction in
other sample sets.
Results
Sample Sets Studied
We studied ﬁve sets of sarcoidosis samples
and controls (Table 1). Two (sets A and B)
were archival lymph node tissue from
patients undergoing diagnostic biopsy,
where the sarcoidosis tissue studied was
histologically conﬁrmed to show
granulomas. Set A included environmental
control parafﬁn blanks matched to the
individual tissue block and analyzed in
parallel. BAL (set C) was from patients with
untreated pulmonary sarcoidosis and
healthy volunteers. Reasoning that BAL
would most likely reveal a microbial
trigger early in the disease course with
parenchymal lung involvement, we
studied individuals newly presenting with
radiological Scadding stage II/III.
Environmental controls matched to
each sample were prewashes of the
bronchoscope used to collect the BAL.
We analyzed an aliquot of the Kveim
reagent (set D), which is derived from
sarcoidosis-affected human spleen and
used diagnostically by intradermal injection
and monitoring for granuloma formation.
Because this suggests an immunological
response to a triggering antigen (20), we
hypothesized that Kveim reagent may
contain DNA traces of an etiological
microbe. Finally, we tested fresh
sarcoidosis-involved spleen (set E) paired
with blank controls processed in parallel
to model reagent contamination.
Set A: Lymph Node Tissue
Microbial lineages detected in set A
by bacterial 16S and fungal ITS rRNA
gene sequencing are shown as stacked bar
graphs (Figure 1), with dominant taxa
summarized in Figure E2. Each tissue was
paired with a control parafﬁn shaving
from the same sample block. Lymph node
and environmental control samples are
thus plotted side by side. In many cases,
samples and parafﬁn controls appear
similar.
To investigate community structures
in sarcoidosis and healthy lymph node
samples, we calculated the UniFrac
distance between each pair of samples
and tested for clustering using
permutational multivariate analysis of
variance (PERMANOVA) (Figure E3).
Bacterial communities were not signiﬁcantly
different between sarcoidosis and
nonsarcoidosis tissues (Figure E3A), but
fungal communities were different
(Figure E3B; P = 0.027, R2 = 0.037). We
then asked whether community
differences might be attributed to
differential contamination. We performed
the same PERMANOVA test on parafﬁn
controls from sarcoidosis and
nonsarcoidosis samples. No signiﬁcant
difference was detected in bacterial 16S
data (Figure E3C), but we did detect a
difference in fungal ITS data (Figure E3D;
P, 0.002, R2 = 0.091). Review of the
specimen processing pipeline revealed that
most sarcoidosis samples (31 of 45) were
stored in a different building from
nonsarcoidosis controls. A PERMANOVA
test of the effects of storage site on the
parafﬁn environmental controls revealed a
signiﬁcant effect on fungi (P, 0.00001) but
not on bacteria. The environmental fungi
responsible for site-speciﬁc differences were
mostly of the Aspergillaceae family
(negative binomial test, FDR P value =
0.019; Figure E2B).
To account for environmental
admixture statistically, we designed a
GLMM that incorporated each sample’s
matched environmental control (see
METHODS). In short, this approach uses the
matched control to model the background
levels of each taxon. Then, when testing
for differential abundance of that taxon,
the background levels are accounted for by
a separate term in the regression rather
than the study group term. We used this
approach to test for differential abundance
between sarcoidosis and healthy lymph
node at the OTU, species, genus, and family
level.
Among fungi, at the family level,
Cladosporiaceae (within the Capnodiales
order; Figure 1B) was signiﬁcantly enriched
in sarcoidosis (FDR P value = 0.049). At the
OTU level, no individual taxa were
signiﬁcantly enriched after FDR correction,
but two Cladosporium OTUs were
signiﬁcant before FDR correction
(P, 0.05, FDR P = 1). The Cladosporiaceae
fungal lineage is present in both tissue
samples and parafﬁn blank controls but is
most abundant in sarcoidosis tissue
(Figure 1C). No bacterial lineages were
signiﬁcantly enriched in sarcoidosis after
accounting for environmental
contamination.
Set B: Lymph Node Tissue
The dominant bacterial and fungal lineages
in tissue set B are shown in Figure 2, with
rank abundance plots in Figure E4. We
compared community structure using
UniFrac and PERMANOVA (Figure E5)
and found differences in bacterial (but
not fungal) populations between the
Figure 1. (Continued). shown in C. Solid circles represent samples with more Cladosporiaceae reads in the sample than the matched environmental
control, and open circles represent samples in which the number of Cladosporiaceae reads were not greater than in the environment control. The
abundances are shown as reads to more accurately reflect the input to the test, which used raw read counts as input. Normalization between differing
sequencing depths was accounted for by modeling library size as a random effect for each sample (see METHODS).
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sarcoidosis samples and healthy controls
(P, 0.05). We then tested for differentially
abundant taxa at the OTU, species, genus,
and family levels. Numerous bacterial
taxa were signiﬁcantly enriched in
sarcoidosis compared with control tissues
(Table E3), including three OTUs in the
Corynebacterium (order Actinomycetales)
genus (FDR P = 13 1025, 0.064, and 0.067,
respectively) and four OTUs in the
Rhodocyclaceae family (order Rhodocyclales;
FDR P = 0.076, 0.003, 23 1025, and 0.005,
respectively). Other sarcoidosis-enriched
bacteria were from the Sphinogomonadaceae
family (order Sphingomonadales), the
Comamonadaceaea and Oxalobacteraceaea
families (order Burkholderiales), and the
Moraxellaceae and Pseudomonadaceae
families (order Pseudomonadales). No
fungal lineages were sarcoidosis enriched
in tissue set B after FDR correction,
including Cladosporium (although
fungi of this family do appear to be
present in higher levels in the sarcoidosis
samples; Figure E4B). Given the absence
of paired environmental controls, these
results are limited in isolation and serve
mainly for comparison with other sample
sets.
Set C: BAL
We analyzed DNA from whole BAL for
bacteria and fungi using 16S and ITS gene
sequencing (Figure 3, Figure E6), along
with matched bronchoscope prewashes.
Analysis using UniFrac and PERMANOVA
(Figure E7) showed no signiﬁcant
differences between sarcoidosis and control
bacterial communities. To identify taxa
enriched in sarcoidosis while accounting for
environmental input, we used the GLMM
described above. We found that the
bacterial family Corynebacteriaceae (order
Actinomycetales) was enriched in
sarcoidosis before FDR correction, but no
taxa were enriched after FDR correction.
Fungal sequences in BAL were
sparse (Figure 3B), concordant with
previous reports on BAL fungal
detections (25). However, the genus
Aspergillus (within the Eurotiales order;
Figure 3B) was enriched in sarcoidosis
(FDR P = 0.042).
Virome Analysis of Sarcoidosis BAL
We investigated the lung virome in
sarcoidosis by generating virus particle
preparations from acellular BAL and
matched prewashes and deep sequencing
both RNA and DNA. Initial inspection
revealed abundant reads annotated as
HHV6/HHV7. These reads matched human
simple sequence repeats (31) and were
therefore removed. We also purged
sequences that were present in blank
controls and attributable to viral enzymes
used as reagents and thus likely reagent
derived. Our approach was designed to
detect both DNA and RNA viruses, but we
did not recover any RNA viruses that did
not likely originate from reagent
contamination.
The majority of remaining viral
sequences were phages of the Siphoviridae
and Iridoviridae lineages (Figure 3C). The
data initially suggested a much richer
population of viruses in sarcoidosis BAL
than that of healthy control subjects.
However, viral sequences in the sarcoidosis
cohort’s prewash controls were also richer
than the control cohort’s prewash (Figure
E8). This difference is likely because
subjects with sarcoidosis underwent
bronchoscopy in a clinical endoscopy suite,
whereas healthy volunteers were sampled
in a different facility used for research
studies. This suggests that each location
contributed a different environmental
background of virus sequences, likely
originating in lavage saline or water used
to rinse bronchoscopes after cleaning.
We therefore used the same GLMM
approach to account for environmental
differences when testing for enriched viral
species. No viruses were sarcoidosis
enriched at any taxonomic levels tested.
Without accounting for environmental
input, the enrichment analysis would have
been confounded by differences resulting
from bronchoscopy locations.
Sets D and E: Kveim Reagent and
Sarcoidosis Spleen
We analyzed Kveim reagent and fresh
spleen from a patient with sarcoidosis.
Three separate pieces of spleen were tested,
along with controls to capture sequences
from the environment. Kveim, spleen and
controls were subject to 16S and ITS
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Figure 2. Bacterial and fungal lineages in lymph node tissue samples (set B). The major bacterial (A)
and fungal (B) orders identified by 16S ribosomal RNA and internal transcribed spacer (ITS) gene
sequencing are shown as proportions of total reads. Less-common lineages are aggregated under
“Other.” Seventeen samples failed to amplify any usable ITS sequences in B and are omitted. Blank
paraffin controls matched to each tissue specimen were not available for these samples.
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sequence analysis (Figures 4A and 4B)
and also shotgun WGS (Figure 4C). WGS
yielded mostly human sequences, which
were removed; the remaining sequences
were queried for microbial annotations.
The predominant bacteria found
by both 16S and WGS were in the
Propionibacteriaceae family (within the
Actinomycetales order) and were
detected across all samples, including
controls. Other ubiquitous taxa included
Corynebacteriaceae and Pseudomonadaceae
(of the Actinomycetales and Pseudomonadales
orders, respectively). Some differences were
seen between 16S and WGS analysis for
other taxa, likely resulting from the relative
representation of sequences within 16S and
WGS databases. No taxa were present only
in sarcoidosis samples and not
environmental controls.
Fungal detections were sparse in both
ITS sequencing and WGS and inconsistent
between methods. Cladosporiaceae (order
Capnodiales) was detected by ITS in one
spleen sample, but not byWGS. This may be
due to a paucity of database genomic
sequences for Cladosporiaceae, limiting
detection in WGS annotation. There was no
consistent fungal detection in sarcoidosis
samples versus controls.
In the WGS data, we initially detected
alignments annotated as Toxoplasma gondii
in the Kveim and spleen samples. We
also detected reads annotating to an
unﬁnished Mycobacteria genome. However,
these sequences were found to match human
microsatellite simple repeats and so were
judged to be false positives and removed
(detailed in the online supplement). This is
an issue for WGS data but not for 16S or ITS
analysis, as the untargeted approach allowed
capture of low-complexity repeat DNA.
The only viral reads detected were from
bacteriophages and were also found in the
controls; they were thus inferred to be
environmentally derived.
Shared Lineages
No bacterial or fungal lineages were
signiﬁcantly enriched after FDR correction
in more than one sample set. To broaden
our search, we examined lineages that were
signiﬁcantly enriched in one sample set
after FDR correction and queried their
abundance in the other sets. Enriched
lineages are summarized in Table 2.
In tissue set A, fungi from the
Cladosporiaceae family (order Capnodiales)
were signiﬁcantly enriched in sarcoidosis
when tested as a group. A single
Cladosporium OTU (OTU7142) was
enriched in tissue set B before multiple
testing correction (P = 0.042), although not
the Cladosporiaceae family overall.
Cladosporiaceae were detected but not
enriched in sarcoidosis BAL. Finally,
abundant Cladosporium reads were
detected in one of three replicate spleen
samples via ITS sequencing and not in the
environmental controls, although it was not
in WGS of spleen or Kveim.
In tissue set B, three OTUs belonging
to the Corynebacterium bacterial genus
(order Actinomycetales) were signiﬁcantly
enriched in sarcoidosis. Although no
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Figure 3. Bacterial, fungal, and viral lineages in BAL (sample set C). The major bacterial (A) and fungal (B) lineages identified by 16S ribosomal RNA (rRNA) and internal
transcribed spacer (ITS) rRNA sequencing and viral (C) lineages identified by shotgun sequencing of all nucleic acids in virus particle preparations are shown as
proportions of the total reads. Data are shown at the order level for A and B and the family level for C. Less-common lineages are aggregated under “Other.” For each
pair, the solid circle indicates the BAL fluid, and the open circle represents the prewash fluid for that scope. Empty (white) bar charts indicate that the sample was either
not collected or had no detectable lineages. Three sample pairs failed to amplify any ITS sequences and are omitted from B.
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individual Corynebacterium OTUs were
enriched in other sample sets, the
Corynebacterium genus was enriched in
sarcoidosis BAL before FDR correction
(P = 0.02). Corynebacterium was detected
but was not sarcoidosis enriched in tissue
set A and was also detected in Kveim and
spleen, as well as environmental controls.
Also in tissue set B, multiple OTUs in
the Rhodocyclaceae (order Rhodocyclales)
bacterial family were signiﬁcantly enriched.
A single Rhodocyclaceae OTU was enriched
in BAL before FDR correction (OTU104987,
genus Hydrogenophilus; P = 0.009). No
Rhodocyclaceae lineages were detected in
tissue set A, but they appeared in both
Kveim and spleen as well as controls from
sets D and E.
In BAL (set C), fungi in the Aspergillus
genus (order Eurotiales) were signiﬁcantly
enriched in sarcoidosis. Aspergillus was
detected in tissue set A but was not
sarcoidosis enriched. Numerous Aspergillus
lineages were also detected but not
sarcoidosis enriched in tissue set B.
Aspergillus species were not detected in
Kveim or spleen in sets D and E but were
found in the environmental and blank
controls by WGS.
Discussion
This is the ﬁrst study to interrogate
microbial agents in sarcoidosis using a
metagenomic approach combining bacterial
and fungal sequence tag analysis, virome
shotgun sequencing, and WGS. We
anticipated that a causal microbe would be
present in low abundance, so rigorous
consideration of potential contamination
would be critical for distinguishing
authentic from environmentally derived
sequences. Our ﬁndings were inconsistent
across the ﬁve sample sets analyzed (Tables
1 and 2) but do provide candidates for
further validation and strongly emphasize
the importance of assessing environmental
contamination.
Cladosporiaceae was signiﬁcantly
enriched in sarcoidosis specimens in tissue
set A after adjustment for environmental
admixture and multiple comparisons and
also appeared in several other sample sets,
although not with comparable statistical
enrichment. Fungi in the Cladosporiaceae
family are extremely common in the
environment (36, 37), can trigger
hypersensitivity pneumonitis and asthma
(38, 39), and are capable of eliciting
granulomatous inﬂammation (24, 40). This
ﬁnding may warrant further investigation.
In tissue set B, we detected multiple
sarcoidosis-enriched taxa, but interpretation
is limited by the lack of matched
environmental controls. Enriched taxa
included several Corynebacterium OTUs,
which were also sarcoidosis enriched
before FDR correction in BAL (set C).
Similarly, OTUs annotated as Rhodocyclaceae
were signiﬁcantly enriched in set B and
enriched before FDR correction in set C.
Corynebacterium are particularly interesting
because they are known to elicit granulomatous
responses in vivo (41, 42), although the
association with sarcoidosis in this study
was weak.
In addition to histopathological
similarities, mycobacteria have been linked
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Figure 4. Microbial lineages in the Kveim reagent (set D) and a granulomatous sarcoid-involved
spleen (set E). The major lineages in sample sets D (Kveim) and E (sarcoidosis spleen) shown by
sequencing. (A) Results from 16S sequencing, (B) internal transcribed spacer sequencing, and
(C) results from whole-genome shotgun sequencing (WGS), after filtering, as described in
the online supplement. Less-common lineages are aggregated under “Other,” including fungal
detections in C.
Table 2. Summary of Taxa Enriched in Sarcoidosis over Controls in Lymph Node
and BAL
FDR P < 0.1 non-FDR P < 0.05
Tissue set A
Bacteria None None
Fungi Cladosporiaceae OTU6408 (genus Cladosporium),
Cladosporiaceae
Tissue set B
Bacteria Many (113),* including
Corynebacterium and
Rhodocyclaceae
Many (252)*
Fungi None Many (149),† including one
Cladosporium OTU (OTU7142)
BAL set C
Bacteria None OTU 104,987 (family
Rhodocyclaceae), OTU 4,301,737
(genus Porphyromonas),
Corynebacterium, Neisseria
Fungi Aspergillus Aspergillus
Viruses None None
Definition of abbreviations: FDR = false discovery rate; OTU = operational taxonomic units.
*See Table E3 for all enriched bacteria in set B.
†See Table E4 for all enriched fungi in set B.
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to sarcoidosis by immunological responses
and/or sequence-based detection (6–9).
However, we did not ﬁnd enrichment of
mycobacteria in sarcoidosis. Mycobacteria
are difﬁcult bacteria from which isolate
DNA due to tough cell walls. To ensure our
methods were robust, we conﬁrmed
detection via sequencing in known
mycobacteria-infected tissue samples
and biological specimens spiked with
avirulent Mycobacterium tuberculosis (not
shown). We also found low levels of
mycobacteria in many samples and
environmental controls. This suggests that
our methods are not inherently insensitive
to mycobacteria but that mycobacteria as a
group were not enriched in these
sarcoidosis specimens. However, the 16S
variable region ampliﬁed, V1V2, cannot
distinguish between mycobacterial
species, which precludes detection of
species-level differences. We also found that
P. acnes was a ubiquitous environmental
agent, concordant with other studies (43),
with no evidence of enrichment in
sarcoidosis.
Environmental admixture is an issue in
any metagenomic survey and becomes
increasingly important as the amount of
authentic microbial content decreases (21).
Such sequences can be introduced from
specimen collection and storage, DNA
extraction kits, the processing pipeline, or
even “barcode error” inherent in Illumina
deep-sequencing platforms that can allow
low-level bleed-over in the sequencing
process (22). Most importantly, in studies
comparing subject groups, clinical samples
collected at different times or locations
may be contaminated with different
environmental sequences. This is especially
problematic when taxa of interest may also
be environmentally present, so simple
subtraction of background lineages is
inappropriate. For example, sarcoidosis and
healthy BALs were acquired in different
locations and showed different background
viromes. For tissue set A, specimen
storage location differed between study
groups, which led to enrichment of
environmental fungi in one group and not
the other.
A key component of our approach is
the generalized linear mixed model, which
enabled us to capture and control the
effects of differential environmental
admixture without losing the ability to
test for differential abundance in
environmental taxa. In tissue set A, without
accounting for environmental input, a naive
enrichment analysis would have identiﬁed
fungal species within the Aspergillus and
Penicillium genera as sarcoidosis enriched.
The same is true for viruses in BAL (set C),
which would have incorrectly identiﬁed
greater phage populations in sarcoidosis.
The GLMM approach presented here
would enable handling of potential
confounding effects of environmental
admixture in microbiome studies generally
and is particularly critical for specimens
with low authentic microbial content when
coupled with appropriate matched
environmental controls for each clinical
sample.
Our study has several limitations. We
investigated microbes that might be
enriched in sarcoidosis at the time of
diagnosis, which is the earliest time point
feasible, but the time from actual disease
onset is unknown, so an etiological trigger
may no longer be present. Conversely, it
is conceivable that microbial enrichment
associated with sarcoidosis could be a
consequence of the disease, rather than a
cause. Use of samples from distinct
geographic locations would reveal shared
lineages, but sarcoidosis triggers may differ
geographically. In addition, any triggers
may not be enriched in subjects with
sarcoidosis at all but may be ubiquitously
present, with disease determined mainly
by host susceptibility factors. Although we
examined a total of 93 sarcoidosis and
72 nonsarcoidosis specimens, plus 150
environmental controls (for a total of 738
sequencing reactions), the number of
samples in any one set was modest. For
the FFPE samples, sensitivity may be
lessened by damage DNA incurred by
during the de-crosslinking step necessary to
undo the formalin ﬁxation (44). For our
DNA virus methods, GenomiPhi
ampliﬁcation may introduce bias toward
short circular DNA due to rolling-circle
ampliﬁcation, although this bias should be
consistent across study groups. Finally, any
primers chosen for tagged sequencing also
have inherent biases and may be more
sensitive to some microbes than others
(such as with the V1V2 primers and
Mycobacterium species, as discussed
previously).
In summary, application of
metagenomic sequencing and analytic
approaches tailored to low–microbial
biomass samples did not identify a single
causative agent but identiﬁed several
candidate agents as sarcoidosis enriched.
These include the Cladosporiaceae fungal
family and Corynebacterium bacterial taxa.
The modest enrichment and limited
concordance of these candidates in the
sample sets precludes our ability to assert
any causal relationship with sarcoidosis, but
we believe these candidates may be of
interest in future studies. More broadly, the
model we present here increases the power
of metagenomic studies in low–microbial
biomass samples, such as lung and tissue
specimens, by allowing researchers to
account for and test environmental
admixture, thus avoiding potential spurious
identiﬁcations. n
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